HONG KONG, July 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody developed by the company. The trial is investigating ivonescimab...
JINJIANG, China, Jan. 14, 2025 /PRNewswire/ -- With the rising demand for high-quality footwear and private-label customization, finding the right shoe manufacturer has become...
CHANGZHOU, China, Jan. 14, 2025 /PRNewswire/ -- Recently, Trina Storage has once again secured a top spot in BloombergNEF's (BNEF) Energy Storage System Cost Survey...
Aiming to export 2 MTPA of green fuels, this partnership positions India as a leader in global decarbonization efforts.
HYDERABAD, India, Jan. 14, 2025 /PRNewswire/...
BEIJING, Jan. 14, 2025 /PRNewswire/ -- On January 9, Spanish premium nutri-cosmetics brand 180 the concept held its "Aesthetic Renaissance" Annual Gala in Partnering with Harper's...
CHANGZHOU, China, Jan. 14, 2025 /PRNewswire/ -- Arctech, the world's leading solar tracking and racking solutions provider, announced that it had signed a supply...